Dermatophytic Onychomycosis Treatment Market

Dermatophytic Onychomycosis Treatment Market

Growth Factors of Dermatophytic Onychomycosis Treatment Market

The dermatophytic onychomycosis treatment market size was valued at USD 4.97 billion in 2023, and the market is now projected to grow from USD 5.34 billion in 2024 to USD 9.52 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2023-2032.

Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the market switched to treating covid patients as priority over the other procedures which led the dermatophytic onychomycosis treatment market growth.

Growing rate of dermatophytic onychomycosis will fuel market expansion during projected period. due to rise in number of onychomycosis patients is one of the main factors promoting the dermatophytic onychomycosis treatment market growth in the upcoming years. The presence of potential pipeline candidates to promote market growth. Additionally, podiatrists and dermatologists across the globe believe that there is a critical need for improved topical remedies over those currently available.

The most recent trend is a gradual shift toward topical solutions during projected period. A significant development in the industry is the increasing inclination towards topical treatment options. Patients with heart and liver conditions should not be taken oral antifungal medications due to their link to liver damage. Because of this, effective topical therapies may be the better option in some situations but not in others.

Comprehensive Analysis of Dermatophytic Onychomycosis Treatment Market

The dermatophytic onychomycosis treatment market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by product types, by route of administration, by type and by distribution channel. The product types segmentations include, Tablets and Nail Paints), By Route of Administration (Oral and Topical), and by Type segmentations include Prescribed and Over-the-Counter (OTC)). However, the Distribution Channel segmentations include Hospital Pharmacies, Retail Pharmacies, and Online Channels.

The North America region lead the dermatophytic onychomycosis treatment market by benefitting a market size of USD 2.20 billion in 2023 due to Growing research, more onychomycosis prescriptions written, and more new medication applications submitted to regulatory bodies.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Bausch Health Companies Inc. (Canada), Pfizer Inc. (U.S.), Galderma (Switzerland), GlaxoSmithKline plc (U.K.), Janssen Pharmaceuticals, Inc. (U.S.), Cipla Inc. (India), Kaken Pharmaceuticals Co., Ltd. (Japan) these market players provide a level-playing competitive landscape.

In December 2022, An novel approach to curing onychomycosis has ot patented, as per the statement made by Bausch Health Companies Inc.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

CAGR Growth rate of 7.5% from 2024 to 2032

Unit Volume (K Units)

Segmentation By Product Type

• Tablets
• Nail Paints

By Route of Administration

• Oral
• Topical

By Type

• Prescribed
• Over-the-Counter (OTC

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Channels

By Geography

• North America (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country)
• U.S.
• Canada
• Europe (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country/Sub-region)
• U.K.
• Germany
• France
• Italy
• Spain
• Scandinavia
• Russia
• Rest of Europe
• Asia Pacific (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country/Sub-region)
• Japan
• China
• India
• Australia
• New Zealand
• Southeast Asia
• Rest of Asia Pacific

Please Note: It will take 5-6 business days to complete the report upon order confirmation.